{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:56:35Z","timestamp":1792803395225,"version":"4.5.0"},"reference-count":303,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T00:00:00Z","timestamp":1484784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Colorectal cancer (CRC) is the third most common cancer and the fourth most common cause of cancer-related death. Most cases of CRC are detected in Western countries, with its incidence increasing year by year. The probability of suffering from colorectal cancer is about 4%\u20135% and the risk for developing CRC is associated with personal features or habits such as age, chronic disease history and lifestyle. In this context, the gut microbiota has a relevant role, and dysbiosis situations can induce colonic carcinogenesis through a chronic inflammation mechanism. Some of the bacteria responsible for this multiphase process include Fusobacterium spp, Bacteroides fragilis and enteropathogenic Escherichia coli. CRC is caused by mutations that target oncogenes, tumour suppressor genes and genes related to DNA repair mechanisms. Depending on the origin of the mutation, colorectal carcinomas can be classified as sporadic (70%); inherited (5%) and familial (25%). The pathogenic mechanisms leading to this situation can be included in three types, namely chromosomal instability (CIN), microsatellite instability (MSI) and CpG island methylator phenotype (CIMP). Within these types of CRC, common mutations, chromosomal changes and translocations have been reported to affect important pathways (WNT, MAPK\/PI3K, TGF-\u03b2, TP53), and mutations; in particular, genes such as c-MYC, KRAS, BRAF, PIK3CA, PTEN, SMAD2 and SMAD4 can be used as predictive markers for patient outcome. In addition to gene mutations, alterations in ncRNAs, such as lncRNA or miRNA, can also contribute to different steps of the carcinogenesis process and have a predictive value when used as biomarkers. In consequence, different panels of genes and mRNA are being developed to improve prognosis and treatment selection. The choice of first-line treatment in CRC follows a multimodal approach based on tumour-related characteristics and usually comprises surgical resection followed by chemotherapy combined with monoclonal antibodies or proteins against vascular endothelial growth factor (VEGF) and epidermal growth receptor (EGFR). Besides traditional chemotherapy, alternative therapies (such as agarose tumour macrobeads, anti-inflammatory drugs, probiotics, and gold-based drugs) are currently being studied to increase treatment effectiveness and reduce side effects.<\/jats:p>","DOI":"10.3390\/ijms18010197","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T10:55:40Z","timestamp":1484823340000},"page":"197","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1269,"title":["Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer"],"prefix":"10.3390","volume":"18","author":[{"given":"In\u00e9s","family":"M\u00e1rmol","sequence":"first","affiliation":[{"name":"Departamento de Farmacolog\u00eda y Fisiolog\u00eda, Facultad de Veterinaria, Universidad de Zaragoza, 50013 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"S\u00e1nchez-de-Diego","sequence":"additional","affiliation":[{"name":"Departamento de Farmacolog\u00eda y Fisiolog\u00eda, Facultad de Veterinaria, Universidad de Zaragoza, 50013 Zaragoza, Spain"},{"name":"Departament de Ciencies Fisiologiques II, Universitat de Barcelona, L\u2019hospitalet de Llobregat, 08007 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pradilla Dieste","sequence":"additional","affiliation":[{"name":"Departamento de Farmacolog\u00eda y Fisiolog\u00eda, Facultad de Veterinaria, Universidad de Zaragoza, 50013 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2457-3674","authenticated-orcid":false,"given":"Elena","family":"Cerrada","sequence":"additional","affiliation":[{"name":"Departamento de Qu\u00edmica Inorg\u00e1nica, Facultad de Ciencias, Universidad de Zaragoza, 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Rodriguez Yoldi","sequence":"additional","affiliation":[{"name":"Departamento de Farmacolog\u00eda y Fisiolog\u00eda, Facultad de Veterinaria, Universidad de Zaragoza, 50013 Zaragoza, Spain"},{"name":"Ciber de Fisiopatolog\u00eda de la Obesidad y la Nutrici\u00f3n (CIBERobn), Instituto Agroalimentario de Arag\u00f3n (IA2), (Instituto de Investigaciones Sanitarias de Arag\u00f3n IIS Arag\u00f3)n, 50008 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,1,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/nar\/gku988","article-title":"LncRNAdb v2. 0: Expanding the reference database for functional long noncoding RNAs","volume":"43","author":"Quek","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/nar\/gkq1138","article-title":"LncRNAdb: A reference database for long noncoding RNAs","volume":"39","author":"Amaral","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/bioinformatics\/btt014","article-title":"miRCancer: A microRNA-cancer association database constructed by text mining on literature","volume":"29","author":"Xie","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Xie, B., Ding, Q., and Wu, D. (2014). Text mining on big and complex biomedical literature. Big Data Anal. Bioinform. Healthc.","DOI":"10.4018\/978-1-4666-6611-5.ch002"},{"key":"ref_5","unstructured":"Xie, B., Hochberg, R., Ding, Q., and Wu, D. (2010, January 24\u201326). miRSAT & miRCDB: An Integrated microRNA Sequesce Analysis Tool and a Cancer-Associated microRNA Database. Proceedings of the ISCA 2nd International Conference on Bioinformatics and Computational Biology, BICoB-2010, Sheraton Waikiki Hotel, Honolulu, HI, USA."},{"key":"ref_6","unstructured":"Stewart, B., and Wild, C.P. (2014). World Cancer Report 2014, International Agency for Research on Cancer (IARC)."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/521S1a","article-title":"Colorectal cancer","volume":"521","author":"Brody","year":"2015","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(10)60353-4","article-title":"Colorectal cancer","volume":"375","author":"Cunningham","year":"2010","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra012242","article-title":"Hereditary colorectal cancer","volume":"348","author":"Lynch","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised bethesda guidelines for hereditary nonpolyposis colorectal cancer (lynch syndrome) and microsatellite instability","volume":"96","author":"Umar","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cgh.2013.08.015","article-title":"Familial colorectal cancer, beyond lynch syndrome","volume":"12","author":"Stoffel","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3322\/CA.2007.0018","article-title":"Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American cancer society, the US multi-society task force on colorectal cancer, and the American college of radiology","volume":"58","author":"Levin","year":"2008","journal-title":"CA Cancer J. Clin."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: A meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2036.2006.02854.x","article-title":"Meta-analysis: Colorectal and small bowel cancer risk in patients with crohn\u2019s disease","volume":"23","author":"Canavan","year":"2006","journal-title":"Aliment. Pharmacol. Therap."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1111\/j.1572-0241.2001.04677.x","article-title":"A systematic review and meta-analysis of familial colorectal cancer risk","volume":"96","author":"Johns","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.gastro.2012.07.090","article-title":"ABC of colorectal cancer","volume":"143","author":"Robertson","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12967-016-0772-5","article-title":"Obesity and colorectal cancer: Molecular features of adipose tissue","volume":"14","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/jama.293.2.233","article-title":"Diet and cancer: An evolving picture","volume":"293","author":"Willett","year":"2005","journal-title":"JAMA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1158\/1940-6207.CAPR-10-0113","article-title":"Heme iron from meat and risk of colorectal cancer: A meta-analysis and a review of the mechanisms involved","volume":"4","author":"Bastide","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/01635580701684872","article-title":"Processed meat and colorectal cancer: A review of epidemiologic and experimental evidence","volume":"60","author":"Santarelli","year":"2008","journal-title":"Nutr. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/alcalc\/agh057","article-title":"Alcohol and cancer","volume":"39","author":"Seitz","year":"2004","journal-title":"Alcohol Alcoholism"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1001\/jama.2008.839","article-title":"Smoking and colorectal cancer: A meta-analysis","volume":"300","author":"Botteri","year":"2008","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/carcin\/bgu071","article-title":"Metabolites of tobacco smoking and colorectal cancer risk","volume":"35","author":"Cross","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1002\/ijc.24191","article-title":"Cigarette smoking and colorectal cancer incidence and mortality: Systematic review and meta-analysis","volume":"124","author":"Liang","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1053\/j.gastro.2008.07.076","article-title":"Genomic and epigenetic instability in colorectal cancer pathogenesis","volume":"135","author":"Grady","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1053\/j.gastro.2009.12.065","article-title":"The chromosomal instability pathway in colon cancer","volume":"138","author":"Pino","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","article-title":"Microsatellite instability in colorectal cancer","volume":"138","author":"Boland","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2011.173","article-title":"Epigenetics and colorectal cancer","volume":"8","author":"Lao","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/ng1834","article-title":"CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer","volume":"38","author":"Weisenberger","year":"2006","journal-title":"Nat. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Cancer genome atlas network. Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Willett","year":"2012","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tcb.2008.09.002","article-title":"APC shuttling to the membrane, nucleus and beyond","volume":"18","author":"Brocardo","year":"2008","journal-title":"Trends Cell Boil."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/jso.23806","article-title":"Molecular markers for colon diagnosis, prognosis and targeted therapy","volume":"111","author":"Herzig","year":"2015","journal-title":"J. Surg. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4331\/wjbc.v6.i4.290","article-title":"Regulation of myc gene expression by aberrant Wnt\/\u03b2-catenin signaling in colorectal cancer","volume":"6","author":"Rennoll","year":"2015","journal-title":"World J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Toon, C.W., Chou, A., Clarkson, A., DeSilva, K., Houang, M., Chan, J.C.Y., Sioson, L.L., Jankova, L., and Gill, A.J. (2014). Immunohistochemistry for myc predicts survival in colorectal cancer. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087456"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Chen, J., Guo, F., Shi, X., Zhang, L., Zhang, A., Jin, H., and He, Y. (2014). BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-802"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Li, W., Qiu, T., Zhi, W., Shi, S., Zou, S., Ling, Y., Shan, L., Ying, J., and Lu, N. (2015). Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1345-3"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.2008.155473","article-title":"CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer","volume":"58","author":"Ogino","year":"2009","journal-title":"Gut"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/annonc\/mdu100","article-title":"Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)","volume":"25","author":"Goldstein","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3748\/wjg.v21.i4.1275","article-title":"Prognostic value of KRAS and BRAF mutations in curatively resected colorectal cancer","volume":"21","author":"Kadowaki","year":"2015","journal-title":"World J. Gastroenterol. WJG"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11523-014-0319-8","article-title":"A mutant BRAF V600E-specific immunohistochemical assay: Correlation with molecular mutation status and clinical outcome in colorectal cancer","volume":"10","author":"Day","year":"2015","journal-title":"Target. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1158\/1078-0432.CCR-14-2779","article-title":"Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients","volume":"21","author":"Yaeger","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"20785","DOI":"10.18632\/oncotarget.4750","article-title":"Similar but different: Distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance","volume":"6","author":"Morkel","year":"2015","journal-title":"Oncotarget"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Rosty, C., Young, J.P., Walsh, M.D., Clendenning, M., Sanderson, K., Walters, R.J., Parry, S., Jenkins, M.A., Win, A.K., and Southey, M.C. (2013). PIK3CA activating mutation in colorectal carcinoma: Associations with molecular features and survival. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0065479"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1158\/1078-0432.CCR-11-2410","article-title":"Prognostic role of PIK3CA mutation in colorectal cancer: Cohort study and literature review","volume":"18","author":"Liao","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/cam4.97","article-title":"PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival","volume":"2","author":"Atreya","year":"2013","journal-title":"Cancer Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s10350-004-0628-6","article-title":"Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q","volume":"47","author":"Sarli","year":"2004","journal-title":"Dis. Colon Rectum."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.ejca.2005.04.039","article-title":"A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis","volume":"41","author":"Popat","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"ref_49","first-page":"627","article-title":"Relationship between chromosome 18q status and colorectal cancer prognosis: A prospective, blinded analysis of 280 patients","volume":"27","author":"Popat","year":"2007","journal-title":"Anticancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.bjc.6602358","article-title":"P53 abnormalities and outcomes in colorectal cancer: A systematic review","volume":"92","author":"Munro","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1054\/bjoc.2001.2095","article-title":"Colorectal cancer genomics: Evidence for multiple genotypes which influence survival","volume":"85","author":"Rooney","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1093\/hmg\/ddl046","article-title":"Non-coding RNA","volume":"15","author":"Mattick","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"13421","DOI":"10.1073\/pnas.0801613105","article-title":"mir-34a repression of SIRT1 regulates apoptosis","volume":"105","author":"Yamakuchi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.yexmp.2015.06.014","article-title":"MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer","volume":"99","author":"Lu","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1673-8527(09)60053-9","article-title":"The role of microRNAs in colorectal cancer","volume":"37","author":"Liu","year":"2010","journal-title":"J. Genet. Genom."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Migliore, L., Migheli, F., Spisni, R., and Copped\u00e8, F. (2011). Genetics, cytogenetics, and epigenetics of colorectal cancer. BioMed Res. Int., 2011.","DOI":"10.1155\/2011\/792362"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/sj.onc.1210856","article-title":"microRNA-21 (mir-21) post-transcriptionally downregulates tumor suppressor PDCD4 and stimulates invasion, intravasation and metastasis in colorectal cancer","volume":"27","author":"Asangani","year":"2008","journal-title":"Oncogene"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/carcin\/bgr114","article-title":"MicroRNA 345, a methylation-sensitive microrna is involved in cell proliferation and invasion in human colorectal cancer","volume":"32","author":"Tang","year":"2011","journal-title":"Carcinogenesis"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ijc.26485","article-title":"MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer","volume":"131","author":"Song","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/path.3014","article-title":"LET-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer","volume":"226","author":"Han","year":"2012","journal-title":"J. Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.canlet.2011.09.033","article-title":"NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by LET-7a microRNA","volume":"314","author":"Wang","year":"2012","journal-title":"Cancer Lett."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/carcin\/bgr213","article-title":"microRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4","volume":"32","author":"Liu","year":"2011","journal-title":"Carcinogenesis"},{"key":"ref_63","first-page":"283","article-title":"MicroRNA-92a promotes colorectal cancer cell growth and migration by inhibiting KLF4","volume":"23","author":"Lv","year":"2016","journal-title":"Oncol. Res. Featur. Preclin. Clin. Cancer Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1590\/S0102-86502016001300004","article-title":"Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer","volume":"31","author":"Almeida","year":"2016","journal-title":"Acta Cir. Bras."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Vishnubalaji, R., Hamam, R., Yue, S., Al-Obeed, O., Kassem, M., Liu, F., Aldahmash, A., and Alajez, N. (2016). MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1. Oncotarget.","DOI":"10.18632\/oncotarget.8937"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"24448","DOI":"10.18632\/oncotarget.4423","article-title":"miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mtor","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3892\/ijo.2016.3430","article-title":"microRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer","volume":"48","author":"Park","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000444493","article-title":"miRNA-503 promotes tumor progression and is associated with early recurrence and poor prognosis in human colorectal cancer","volume":"90","author":"Noguchi","year":"2016","journal-title":"Oncology"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Gao, H., Bai, C., and Sun, Z. (June, January 29). In microRNA-222 to enhance invasion and migration through MST3 in colorectal cancer and to predict for CRC patients progression. Proceedings of the 2015 ASCO Annual Meeting Proceedings, Chicago, IL, USA.","DOI":"10.1200\/jco.2015.33.15_suppl.e22006"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3892\/ijo.2016.3414","article-title":"Epigenetic silencing of mir-181b contributes to tumorigenicity in colorectal cancer by targeting RASSF1A","volume":"48","author":"Zhao","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/cpr.12237","article-title":"microRNA-497 inhibits invasion and metastasis of colorectal cancer cells by targeting vascular endothelial growth factor-A","volume":"49","author":"Qiu","year":"2016","journal-title":"Cell Prolif."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s13277-015-3750-2","article-title":"Association between polymorphisms in long non-coding RNA PRNCR1 in 8q24 and risk of gastric cancer","volume":"37","author":"Li","year":"2016","journal-title":"Tumor Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2016.01.037","article-title":"microRNA-187, a downstream effector of TGF-\u03b2 pathway, suppresses SMAD-mediated epithelial-mesenchymal transition in colorectal cancer","volume":"373","author":"Zhang","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10620-015-4029-6","article-title":"ORAI1, a direct target of microRNA-519, promotes progression of colorectal cancer via AKT\/GSK3\u0392 signaling pathway","volume":"61","author":"Deng","year":"2016","journal-title":"Digest. Dis. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Wan, Y.C., Li, T., Han, Y.D., Zhang, H.Y., Lin, H., and Zhang, B. (2016). microRNA-155 enhances the activation of WNT\/\u03b2-catenin signaling in colorectal carcinoma by suppressing HMG-box transcription factor 1. Mol. Med. Rep.","DOI":"10.3892\/mmr.2016.4788"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.18632\/oncotarget.6545","article-title":"MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1","volume":"7","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"435","DOI":"10.15403\/jgld.2014.1121.244.375","article-title":"Exosome-carried microRNA-375 inhibits cell progression and dissemination via Bcl-2 blocking in colon cancer","volume":"24","author":"Zaharie","year":"2015","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3892\/mmr.2015.4557","article-title":"microRNA-1246 promotes growth and metastasis of colorectal cancer cells involving CCNG2 reduction","volume":"13","author":"Wang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.biopha.2015.08.006","article-title":"miRNA-144 suppresses proliferation and migration of colorectal cancer cells through GSPT1","volume":"74","author":"Xiao","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s13238-015-0187-8","article-title":"microRNA-638 inhibits cell proliferation by targeting phospholipase D1 in human gastric carcinoma","volume":"6","author":"Zhang","year":"2015","journal-title":"Protein Cell"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bbrc.2015.06.041","article-title":"microRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells","volume":"463","author":"Chen","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3892\/etm.2015.2538","article-title":"microRNA-20a enhances the epithelial-to-mesenchymal transition of colorectal cancer cells by modulating matrix metalloproteinases","volume":"10","author":"Xu","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/ijc.29607","article-title":"microRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression","volume":"137","author":"Bai","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrg3722","article-title":"The rise of regulatory RNA","volume":"15","author":"Morris","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"ref_85","first-page":"127","article-title":"natures: Versatile master regulators of gene expression and crucial players in cancer","volume":"4","author":"Nie","year":"2012","journal-title":"Am. J. Transl. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3934\/biophy.2015.4.794","article-title":"The interplay of long non-coding RNAs and myc in cancer","volume":"2","author":"Hamilton","year":"2015","journal-title":"AIMS Biophys."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-10-38","article-title":"The functional role of long non-coding RNA in human carcinomas","volume":"10","author":"Gibb","year":"2011","journal-title":"Mol. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/carcin\/bgp181","article-title":"Oncofetal H19-derived mir-675 regulates tumor suppressor RB in human colorectal cancer","volume":"31","author":"Tsang","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/jcp.2004.023648","article-title":"H19 expression in hepatic metastases from a range of human carcinomas","volume":"58","author":"Fellig","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jgm.670","article-title":"Regulatory sequences of H19 and IGF2 genes in DNA-based therapy of colorectal rat liver metastases","volume":"7","author":"Ohana","year":"2005","journal-title":"J. Gene Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08975","article-title":"Long non-coding RNA hotair reprograms chromatin state to promote cancer metastasis","volume":"464","author":"Gupta","year":"2010","journal-title":"Nature"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Schorderet, P., and Duboule, D. (2011). Structural and functional differences in the long non-coding RNA hotair in mouse and human. PLoS Genet, 7.","DOI":"10.1371\/journal.pgen.1002071"},{"key":"ref_93","first-page":"169","article-title":"Malat-1: A long non-coding RNA and its important 3\u2032 end functional motif in colorectal cancer metastasis","volume":"39","author":"Xu","year":"2011","journal-title":"Int. J. Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/MEG.0b013e328306a3a2","article-title":"Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis","volume":"21","author":"Matouk","year":"2009","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1210\/jc.2003-030222","article-title":"A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells","volume":"88","author":"Zhang","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00432-012-1324-x","article-title":"Long noncoding RNA CCAT1, which could be activated by c-myc, promotes the progression of gastric carcinoma","volume":"139","author":"Yang","year":"2013","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1073\/pnas.1400350111","article-title":"Long\u2013Range interaction and correlation between myc enhancer and oncogenic long noncoding RNA CARLO-5","volume":"111","author":"Kim","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1101\/gr.152942.112","article-title":"CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer","volume":"23","author":"Ling","year":"2013","journal-title":"Genome Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/1947601911431081","article-title":"Colorectal neoplasia differentially expressed (CRNDE), a novel gene with elevated expression in colorectal adenomas and adenocarcinomas","volume":"2","author":"Graham","year":"2011","journal-title":"Gene Cancer"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1093\/nar\/gkt182","article-title":"LncRNA loc285194 is a p53-regulated tumor suppressor","volume":"41","author":"Liu","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-4608(01)00634-3","article-title":"Cloning of the mRNA of overexpression in colon carcinoma-1: A sequence overexpressed in a subset of colon carcinomas","volume":"133","author":"Pibouin","year":"2002","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.molcel.2013.11.004","article-title":"Reciprocal regulation of HIF-1\u03b1 and lincRNA-p21 modulates the Warburg effect","volume":"53","author":"Yang","year":"2014","journal-title":"Mol. Cell"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1349-7006.2006.00305.x","article-title":"Expression profile of LIT1\/KCNQ1OT1 and epigenetic status at the KVDMR1 in colorectal cancers","volume":"97","author":"Nakano","year":"2006","journal-title":"Cancer Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nature09144","article-title":"A coding-independent function of gene and pseudogene mRNAs regulates tumour biology","volume":"465","author":"Poliseno","year":"2010","journal-title":"Nature"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1096\/fj.10-177808","article-title":"A transcribed pseudogene of MYLK promotes cell proliferation","volume":"25","author":"Han","year":"2011","journal-title":"FASEB J."},{"key":"ref_106","first-page":"1029","article-title":"The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1 isoform 1","volume":"20","author":"Panagopoulos","year":"2008","journal-title":"Oncol. Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.febslet.2008.05.012","article-title":"UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion","volume":"582","author":"Wang","year":"2008","journal-title":"FEBS Lett."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/nbt.1914","article-title":"Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression","volume":"29","author":"Prensner","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1158\/0008-5472.CAN-13-3159","article-title":"PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer","volume":"74","author":"Prensner","year":"2014","journal-title":"Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-013-0588-6","article-title":"Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer","volume":"30","author":"Ge","year":"2013","journal-title":"Med. Oncol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1349-7006.2010.01737.x","article-title":"Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility","volume":"102","author":"Chung","year":"2011","journal-title":"Cancer Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-9966-32-104","article-title":"Association between polymorphisms in long non-coding RNA PRNCR1 in 8q24 and risk of colorectal cancer","volume":"32","author":"Li","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.molcel.2013.01.010","article-title":"Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis","volume":"49","author":"Yang","year":"2013","journal-title":"Mol. Cell"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/mc.22137","article-title":"Down-regulation of NCRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients","volume":"54","author":"Qi","year":"2015","journal-title":"Mol. Carcinog."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nature13311","article-title":"PVT1 dependence in cancer with myc copy-number increase","volume":"512","author":"Tseng","year":"2014","journal-title":"Nature"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/bjc.2013.698","article-title":"Amplification of PVT1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers","volume":"110","author":"Takahashi","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_117","first-page":"93","article-title":"Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle","volume":"10","author":"Ahmed","year":"2013","journal-title":"Cancer Genom. Proteom."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1007\/s13277-014-2890-0","article-title":"The expression and clinical significance of microRNAs in colorectal cancer detecting","volume":"36","author":"Yang","year":"2015","journal-title":"Tumor Biol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1111\/j.1753-4887.2012.00493.x","article-title":"Defining the human microbiome","volume":"70","author":"Ursell","year":"2012","journal-title":"Nutr. Rev."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"McNally, L., and Brown, S.P. (2015). Building the microbiome in health and disease: Niche construction and social conflict in bacteria. Phil. Trans. R. Soc. B.","DOI":"10.1098\/rstb.2014.0298"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.dld.2015.07.008","article-title":"The human gut microbiota and virome: Potential therapeutic implications","volume":"47","author":"Scarpellini","year":"2011","journal-title":"Dig. Liver Dis."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Stearns, J.C., Lynch, M.D.J., Senadheera, D.B., Tenenbaum, H.C., Goldberg, M.B., Cvitkovitch, D.G., Croitoru, K., Moreno-Hagelsieb, G., and Neufeld, J.D. (2011). Bacterial biogeography of the human digestive tract. Sci. Rep., 1.","DOI":"10.1038\/srep00170"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/j.1462-2920.2007.01369.x","article-title":"Diversity of the human gastrointestinal tract microbiota revisited","volume":"9","author":"Smidt","year":"2007","journal-title":"Environ. Microbial."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tim.2012.12.001","article-title":"Development of intestinal microbiota in infants and its impact on health","volume":"21","author":"Matamoros","year":"2013","journal-title":"Trends Microbial."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13099-016-0099-z","article-title":"Global investigation of composition and interaction networks in gut microbiomes of individuals belonging to diverse geographies and age-groups","volume":"8","author":"Yadav","year":"2016","journal-title":"Gut Pathog."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature11053","article-title":"Human gut microbiome viewed across age and geography","volume":"486","author":"Yatsunenko","year":"2012","journal-title":"Nature"},{"key":"ref_127","first-page":"223","article-title":"The gastrointestinal microbiome: Alcohol effects on the composition of intestinal microbiota","volume":"37","author":"Engen","year":"2015","journal-title":"Alcohol Res. Curr. Rev."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S0007114514004127","article-title":"Dietary effects on human gut microbiome diversity","volume":"113","author":"Xu","year":"2015","journal-title":"Br. J. Nutr."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1126\/science.1155725","article-title":"Evolution of mammals and their gut microbes","volume":"320","author":"Ley","year":"2008","journal-title":"Science"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Davenport, E.R., Mizrahi-Man, O., Michelini, K., Barreiro, L.B., Ober, C., and Gilad, Y. (2014). Seasonal variation in human gut microbiome composition. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090731"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.syapm.2015.03.004","article-title":"The human gut microbiome, a taxonomic conundrum","volume":"38","author":"Sankar","year":"2015","journal-title":"Syst. Appl. Microbial."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/hmg\/ddt398","article-title":"Sequencing the human microbiome in health and disease","volume":"22","author":"Cox","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1007\/s00018-015-2004-1","article-title":"From cultured to uncultured genome sequences: Metagenomics and modeling microbial ecosystems","volume":"72","author":"Garza","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4161\/gmic.29330","article-title":"The interplay between the gut microbiota and the immune system","volume":"5","author":"Geuking","year":"2014","journal-title":"Gut Microb."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.coi.2010.06.008","article-title":"Microbiota-stimulated immune mechanisms to maintain gut homeostasis","volume":"22","author":"Chung","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.copbio.2015.08.015","article-title":"Pathways and functions of gut microbiota metabolism impacting host physiology","volume":"36","author":"Krishnan","year":"2015","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"7493","DOI":"10.3390\/ijms16047493","article-title":"Impacts of gut bacteria on human health and diseases","volume":"16","author":"Zhang","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11886-014-0540-1","article-title":"Far from the eyes, close to the heart: Dysbiosis of gut microbiota and cardiovascular consequences","volume":"16","author":"Serino","year":"2014","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.chom.2013.12.010","article-title":"Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE2","volume":"15","author":"Kim","year":"2014","journal-title":"Cell Host Microb."},{"key":"ref_140","first-page":"1","article-title":"Eubiosis and dysbiosis: The two sides of the microbiota","volume":"39","author":"Iebba","year":"2016","journal-title":"New Microbial."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"5786","DOI":"10.3390\/nu6125786","article-title":"Dysbiotic events in gut microbiota: Impact on human health","volume":"6","author":"Schippa","year":"2014","journal-title":"Nutrients"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5217\/ir.2016.14.2.127","article-title":"Pathogenic role of the gut microbiota in gastrointestinal diseases","volume":"14","author":"Kitamoto","year":"2016","journal-title":"Intest. Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.anaerobe.2013.04.006","article-title":"The microbiota and inflammatory bowel disease: Insights from animal models","volume":"24","author":"Peloquin","year":"2013","journal-title":"Anaerobe"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"18121","DOI":"10.3748\/wjg.v20.i48.18121","article-title":"Dismicrobism in inflammatory bowel disease and colorectal cancer: Changes in response of colocytes","volume":"20","author":"Tomasello","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00248-013-0245-9","article-title":"Dysbiosis signature of fecal microbiota in colorectal cancer patients","volume":"66","author":"Wu","year":"2013","journal-title":"Microb. Ecol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11912-014-0406-0","article-title":"Cancer-promoting effects of microbial dysbiosis","volume":"16","author":"Sheflin","year":"2014","journal-title":"Curr. Oncol. Rep."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ismej.2011.109","article-title":"Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers","volume":"6","author":"Wang","year":"2012","journal-title":"ISME J."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ejcn.2011.141","article-title":"A vegan or vegetarian diet substantially alters the human colonic faecal microbiota","volume":"66","author":"Zimmer","year":"2012","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/jnci\/djv246","article-title":"Cross cancer genomic investigation of inflammation pathway for five common cancers: Lung, ovary, prostate, breast, and colorectal cancer","volume":"107","author":"Hung","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20141337","article-title":"Analysis of the intricate relationship between chronic inflammation and cancer","volume":"468","author":"Chai","year":"2015","journal-title":"Biochem. J."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.canep.2014.07.003","article-title":"An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer","volume":"38","author":"Ryan","year":"2015","journal-title":"Cancer Epidemiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1756283X12473674","article-title":"Microbial dysbiosis and colon carcinogenesis: Could colon cancer be considered a bacteria-related disease?","volume":"6","author":"Sobhani","year":"2013","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nrc3610","article-title":"The microbiome and cancer","volume":"13","author":"Schwabe","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_155","first-page":"659","article-title":"Role of colonic microbiota in colorectal carcinogenesis: A systematic review","volume":"107","year":"2015","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3748\/wjg.v20.i4.908","article-title":"Inflammation and colorectal cancer, when microbiota-host mutualism breaks","volume":"20","author":"Candela","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"e00692-13","DOI":"10.1128\/mBio.00692-13","article-title":"The gut microbiome modulates colon tumorigenesis","volume":"4","author":"Zackular","year":"2013","journal-title":"MBio"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3748\/wjg.v22.i2.557","article-title":"Association of fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer","volume":"22","author":"Nosho","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","article-title":"Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment","volume":"14","author":"Kostic","year":"2014","journal-title":"Cell Host Microb."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.3748\/wjg.v22.i11.3227","article-title":"Association of fusobacterium nucleatum infection with colorectal cancer in Chinese patients","volume":"22","author":"Li","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"McCoy, A.N., Araujo-Perez, F., Azcarate-Peril, A., Yeh, J.J., Sandler, R.S., and Keku, T.O. (2013). Fusobacterium is associated with colorectal adenomas. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0053653"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1007\/s13277-015-4724-0","article-title":"Fusobacterium nucleatum, inflammation, and immunity: The fire within human gut","volume":"37","author":"Bashir","year":"2016","journal-title":"Tumor Biol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1172\/JCI72334","article-title":"Bacteroides fragilis subverts mucosal biology: From symbiont to colon carcinogenesis","volume":"124","author":"Sears","year":"2014","journal-title":"J. Clin. Investing."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Boleij, A., Hechenbleikner, E.M., Goodwin, A.C., Badani, R., Stein, E.M., Lazarev, M.G., Ellis, B., Carroll, K.C., Albesiano, E., and Wick, E.C. The bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin. Infect. Dis., 2014.","DOI":"10.1093\/cid\/ciu787"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Kohoutova, D., Smajs, D., Moravkova, P., Cyrany, J., Moravkova, M., Forstlova, M., Cihak, M., Rejchrt, S., and Bures, J. (2014). Escherichia coli strains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia. BMC Infect. Dis., 14.","DOI":"10.1186\/s12879-014-0733-7"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.imlet.2014.05.014","article-title":"Fusobacterium and enterobacteriaceae: Important players for CRC?","volume":"162","author":"Jobin","year":"2014","journal-title":"Immunol. Lett."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/1078-0432.CCR-13-1343","article-title":"Colonization of the human gut by E. Coli and colorectal cancer risk","volume":"20","author":"Bonnet","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_168","first-page":"81","article-title":"Cancer epidemiology and control in peninsular and island South-east Asia-past, present and future","volume":"11","author":"Moore","year":"2010","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_169","unstructured":"Farazi, P.A. (2014). Cancer trends and risk factors in Cyprus. ecancermedicalscience, 8."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.mrrev.2003.07.005","article-title":"Environment and cancer in Brazil: An overview from a public health perspective","volume":"544","author":"Koifman","year":"2003","journal-title":"Rev. Mutat. Res."},{"key":"ref_171","first-page":"97","article-title":"Health effects of changes in the structure of dietary macronutrients intake in western societies","volume":"66","author":"Okreglicka","year":"2015","journal-title":"Rocz. Panstw. Zakl. Hig."},{"key":"ref_172","first-page":"288","article-title":"Red meat and colorectal cancer","volume":"9","author":"Aykan","year":"2015","journal-title":"Oncol. Rev."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.nutres.2013.07.018","article-title":"Review of the association between meat consumption and risk of colorectal cancer","volume":"33","author":"Kim","year":"2013","journal-title":"Nutr. Res."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3945\/ajcn.112.056689","article-title":"Diet, microbiota, and microbial metabolites in colon cancer risk in rural africans and African americans","volume":"98","author":"Ou","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Feng, Q., Liang, S., Jia, H., Stadlmayr, A., Tang, L., Lan, Z., Zhang, D., Xia, H., Xu, X., and Jie, Z. (2015). Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat. Commun., 6.","DOI":"10.1038\/ncomms7528"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"O\u2019Keefe, S.J.D., Li, J.V., Lahti, L., Ou, J., Carbonero, F., Mohammed, K., Posma, J.M., Kinross, J., Wahl, E., and Ruder, E. (2015). Fat, fibre and cancer risk in African americans and rural africans. Nat. Commun., 6.","DOI":"10.1038\/ncomms7342"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1017\/S0007114512001948","article-title":"A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate","volume":"108","author":"Fung","year":"2012","journal-title":"Br. J. Nutr."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2174\/1389201011314030004","article-title":"Regulation of the metabolism of polyunsaturated fatty acids and butyrate in colon cancer cells","volume":"14","author":"Hofmanova","year":"2013","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1158\/2159-8290.CD-14-0501","article-title":"A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner","volume":"4","author":"Donohoe","year":"2014","journal-title":"Cancer Discov."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/jnci\/djq306","article-title":"Cancer biomarkers: Can we turn recent failures into success?","volume":"102","author":"Diamandis","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrc1739","article-title":"Biomarkers in cancer staging, prognosis and treatment selection","volume":"5","author":"Ludwig","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/prca.201400082","article-title":"Biomarkers of colorectal cancer: Recent advances and future challenges","volume":"9","author":"Coghlin","year":"2015","journal-title":"Proteom. Clin. Appl."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1155\/2004\/136734","article-title":"Development of a fluorescent multiplex assay for detection of MSI-high tumors","volume":"20","author":"Bacher","year":"2004","journal-title":"Dis. Mark."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.5858\/arpa.2011-0035-RA","article-title":"Microsatellite instability and colorectal cancer","volume":"135","author":"Geiersbach","year":"2011","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_185","first-page":"1671","article-title":"Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer","volume":"55","author":"Iacopetta","year":"2006","journal-title":"Gut"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1470-2045(10)70130-3","article-title":"Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: A retrospective consortium analysis","volume":"11","author":"Claes","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_187","first-page":"7","article-title":"The relevance of BRAF and extended ras mutational analyses for metastatic colorectal cancer patients","volume":"1","author":"Aprile","year":"2013","journal-title":"OA Mol. Oncol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1023\/A:1015090124153","article-title":"KRAS mutations in sporadic colorectal tumors in Israel: Unusual high frequency of codon 13 mutations and evidence for nonhomogeneous representation of mutation subtypes","volume":"47","author":"Kislitsin","year":"2002","journal-title":"Dig. Dis. Sci."},{"key":"ref_189","first-page":"527","article-title":"Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas","volume":"25","author":"Klintenas","year":"2004","journal-title":"Carcinogenesis"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1200\/JCO.2008.19.5024","article-title":"Using predictive biomarkers to select patients with advanced colorectal cancer for treatment with epidermal growth factor receptor antibodies","volume":"26","author":"Wong","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/0008-5472.CAN-08-2466","article-title":"PIK3CA mutations in colorectal cancer are associated with clinical resistance to egfr-targeted monoclonal antibodies","volume":"69","author":"Martini","year":"2009","journal-title":"Cancer Res."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/jmg.37.8.588","article-title":"The role of hypermethylation of thehmlh1 promoter region in hnpcc versus MSI+ sporadic colorectal cancers","volume":"37","author":"Wheeler","year":"2000","journal-title":"J. Med. Genet."},{"key":"ref_193","first-page":"1","article-title":"Colorectal cancer biomarkers: Where are we now?","volume":"2015","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1373\/clinchem.2006.068577","article-title":"Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: Direct quantitative PCR for alu repeats","volume":"52","author":"Umetani","year":"2006","journal-title":"Clin. Chem."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1200\/JCO.2005.05.0229","article-title":"Stage II colon cancer prognosis prediction by tumor gene expression profiling","volume":"24","author":"Barrier","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2004.08.186","article-title":"Gene expression profiles and molecular markers to predict recurrence of dukes\u2019 B colon cancer","volume":"22","author":"Wang","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1158\/1055-9965.EPI-08-0937","article-title":"Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening","volume":"18","author":"Takai","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1158\/1055-9965.EPI-10-0027","article-title":"Fecal microRNAs as novel biomarkers for colon cancer screening","volume":"19","author":"Link","year":"2010","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1200\/JCO.2006.10.5437","article-title":"Expression of epiregulin and amphiregulin and KRAS mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab","volume":"25","author":"Garrett","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1200\/JCO.2008.21.3744","article-title":"Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab","volume":"27","author":"Jacobs","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/sj.bjc.6606054","article-title":"Tumour gene expression predicts response to cetuximab in patients with kras wild-type metastatic colorectal cancer","volume":"104","author":"Baker","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1572-0241.2007.01126.x","article-title":"Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy","volume":"102","author":"Karamountzos","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/(SICI)1097-0142(19960701)78:1<48::AID-CNCR9>3.0.CO;2-D","article-title":"A new approach to fecal occult blood testing based on the detection of haptoglobin","volume":"78","author":"Xing","year":"1996","journal-title":"Cancer"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.trstmh.2008.04.010","article-title":"Haptoglobin, inflammation and disease","volume":"102","author":"Quaye","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1158\/1055-9965.EPI-06-0994","article-title":"Blood markers for early detection of colorectal cancer: A systematic review","volume":"16","author":"Hundt","year":"2007","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_206","first-page":"156","article-title":"Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer","volume":"8","author":"Christensen","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/annonc\/mdm583","article-title":"Circulating tumor cells in colorectal cancer: Correlation with clinical and pathological variables","volume":"19","author":"Sastre","year":"2008","journal-title":"Ann. Oncol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/annonc\/mdn786","article-title":"Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer","volume":"20","author":"Cohen","year":"2009","journal-title":"Ann. Oncol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1245\/s10434-008-9961-7","article-title":"Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I\u2013III colorectal cancer after curative resection","volume":"15","author":"Uen","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/sj.onc.1207262","article-title":"Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters","volume":"23","author":"Bertucci","year":"2004","journal-title":"Oncogene"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/ijc.24910","article-title":"A blood-based biomarker panel for stratifying current risk for colorectal cancer","volume":"126","author":"Marshall","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-9966-29-128","article-title":"A case-controlled validation study of a blood-based seven-gene biomarker panel for colorectal cancer in Malaysia","volume":"29","author":"Yip","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1200\/JCO.2012.47.3116","article-title":"Validation of the 12-gene colon cancer recurrence score in NSABP C-07 as a predictor of recurrence in patients with stage II and III colon cancer treated with fluorouracil and leucovorin (FU\/LV) and FU\/LV plus oxaliplatin","volume":"31","author":"Yothers","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1634\/theoncologist.2013-0401","article-title":"Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients","volume":"19","author":"Srivastava","year":"2014","journal-title":"Oncologist"},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Salazar, R., Roepman, P., Capella, G., Moreno, V., Simon, I., Dreezen, C., Lopez-Doriga, A., Santos, C., Marijnen, C., and Westerga, J. (2010). Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. J. Clin. Oncol.","DOI":"10.1200\/JCO.2010.30.1077"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/SLA.0b013e31827c1180","article-title":"Independent validation of a prognostic genomic signature (coloprint) for patients with stage II colon cancer","volume":"257","author":"Maak","year":"2013","journal-title":"Ann. Surg."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2011.35.4498","article-title":"Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue","volume":"29","author":"Kennedy","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1158\/1078-0432.CCR-13-1769","article-title":"Anticipating the clinical use of prognostic gene expression-based tests for colon cancer stage II and III: Is godot finally arriving?","volume":"19","author":"Sveen","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1002\/cncr.27628","article-title":"Generation and external validation of a tumor-derived 5-gene prognostic signature for recurrence of lymph node-negative, invasive colorectal carcinoma","volume":"118","author":"Lenehan","year":"2012","journal-title":"Cancer"},{"key":"ref_220","unstructured":"Black, E.R., Falzon, L., and Aronson, N. (2012). Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF03256309","article-title":"Previstage (TM) GCC colorectal cancer staging test: A new molecular test to identify lymph node metastases and provide more accurate information about the stage of patients with colorectal cancer","volume":"13","author":"Carlson","year":"2009","journal-title":"Mol. Diagn. Ther."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/annonc\/mdq222","article-title":"Advanced colorectal cancer: ESMO clinical practice guidelines for treatment","volume":"21","author":"Nordlinger","year":"2010","journal-title":"Ann. Oncol."},{"key":"ref_223","first-page":"1","article-title":"Metastatic colorectal cancer: Esmo clinical practice guidelines for diagnosis, treatment and follow-up","volume":"5","author":"Cervantes","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1634\/theoncologist.10-4-250","article-title":"Critical evaluation of current treatments in metastatic colorectal cancer","volume":"10","author":"Venook","year":"2005","journal-title":"Oncologist"},{"key":"ref_225","first-page":"2","article-title":"The inhibition of tumor growth by tumor mass","volume":"51","author":"Prehn","year":"1991","journal-title":"Cancer Res."},{"key":"ref_226","first-page":"5089","article-title":"Compensatory lung growth after partial pneumonectomy enhances lung tumorigenesis induced by 3-methylcholanthrene","volume":"59","author":"Brown","year":"1999","journal-title":"Cancer Res."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1158\/0008-5472.CAN-10-2258","article-title":"Hydrophilic agarose macrobead cultures select for outgrowth of carcinoma cell populations that can restrict tumor growth","volume":"71","author":"Smith","year":"2011","journal-title":"Cancer Res."},{"key":"ref_228","unstructured":"Asina, S., Jain, K., Rubin, A.L., Smith, B., and Stenzel, K. (2001). Cancer-Cell Proliferation-Suppressing Material Produced by Cancer Cells Restricted by Entrapment. (U.S. 6303151 B1), Google Patents."},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Ocean, A.J., Parikh, T., Berman, N., Escalon, J., Shah, M.A., Andrada, Z., Akahoho, E., Pogoda, J.M., Stoms, G.B., and Escobia, V.B. (June, January 31). Phase I\/II trial of intraperitoneal implantation of agarose-agarose macrobeads (MB) containing mouse renal adenocarcinoma cells (RENCA) in patients (PTS) with advanced colorectal cancer (CRC). Proceedings of the 2013 ASCO Annual Meeting, Chicago, IL, USA.","DOI":"10.1200\/jco.2013.31.15_suppl.e14517"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-0348-0837-8_2","article-title":"The role of inflammation in colon cancer","volume":"816","author":"Janakiram","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/1097-0142(19930815)72:4<1171::AID-CNCR2820720407>3.0.CO;2-D","article-title":"Aspirin use, cancer, and polyps of the large bowel","volume":"72","author":"Suh","year":"1993","journal-title":"Cancer"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"952","DOI":"10.7326\/0003-4819-115-12-952","article-title":"Effects of long-term sulindac therapy on colonic polyposis","volume":"115","author":"Rigau","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1158\/1940-6207.CAPR-11-0222","article-title":"Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65\/\u03b2-catenin\/cyclin D1 signaling pathway in rats","volume":"4","author":"Suh","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejim.2015.03.008","article-title":"Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies","volume":"26","author":"Ungprasert","year":"2015","journal-title":"Eur. J. Intern. Med."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/35094017","article-title":"Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2","volume":"1","author":"Gupta","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0140-6736(04)17514-4","article-title":"Risk of cardiovascular events and rofecoxib: Cumulative meta-analysis","volume":"364","author":"Nartey","year":"2004","journal-title":"Lancet"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The class study: A randomized controlled trial","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/jphp.12372","article-title":"In-vitro characterisation of a novel celecoxib microbead formulation for the treatment and prevention of colorectal cancer","volume":"67","author":"McDonald","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.1158\/1078-0432.CCR-05-0171","article-title":"Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells","volume":"11","author":"Strier","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1099\/jmm.0.048975-0","article-title":"Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives","volume":"62","author":"Kahouli","year":"2013","journal-title":"J. Med. Microbial."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.3748\/wjg.v20.i24.7878","article-title":"Emerging roles of lactic acid bacteria in protection against colorectal cancer","volume":"20","author":"Zhong","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11274-013-1499-6","article-title":"A potential role of probiotics in colorectal cancer prevention: Review of possible mechanisms of action","volume":"30","author":"Chong","year":"2014","journal-title":"World J. Microbiol. Biotechnol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1002\/ijc.26193","article-title":"Yogurt consumption and risk of colorectal cancer in the italian european prospective investigation into cancer and nutrition cohort","volume":"129","author":"Pala","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1017\/S0007114511004934","article-title":"Oral inoculation of probiotics lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue","volume":"107","author":"Chen","year":"2012","journal-title":"Br. J. Nutr."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1472-765X.2006.01913.x","article-title":"Effects of lactobacillus strains on cancer cell proliferation and oxidative stress in vitro","volume":"42","author":"Choi","year":"2006","journal-title":"Lett. Appl. Microbial."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.foodchem.2014.01.105","article-title":"Effect of probiotics on antioxidant and antimutagenic activities of crude peptide extract from yogurt","volume":"156","author":"Sah","year":"2014","journal-title":"Food Chem."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int. J. Biochem. Cell Boil."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.freeradbiomed.2009.12.022","article-title":"Reactive oxygen species, cellular redox systems, and apoptosis","volume":"48","author":"Circu","year":"2010","journal-title":"Free Rad. Biol. Med."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molcel.2012.09.025","article-title":"Physiological roles of mitochondrial reactive oxygen species","volume":"48","author":"Sena","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1021\/jf101394w","article-title":"Studies on chemical constituents and bioactivity of rosa micrantha: An alternative antioxidants source for food, pharmaceutical, or cosmetic applications","volume":"58","author":"Barros","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2174\/092986709787909587","article-title":"Antioxidants in wild mushrooms","volume":"16","author":"Ferreira","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.foodchem.2016.03.085","article-title":"Basil as functional and preserving ingredient in \u201cserra da estrela\u201d cheese","volume":"207","author":"Carocho","year":"2016","journal-title":"Food Chem."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.lwt.2016.02.040","article-title":"Microcapsules containing astaxanthin from shrimp waste as potential food coloring and functional ingredient: Characterization, stability, and bioaccessibility","volume":"70","author":"Montero","year":"2016","journal-title":"LWT Food Sci. Technol."},{"key":"ref_255","unstructured":"Hansen, C. (1995). Grape Seed Extract: Procyanidolic Oligomers (PCO), Healing Wisdom Publications."},{"key":"ref_256","unstructured":"Macheix, J.-J., and Fleuriet, A. (1990). Fruit Phenolics, CRC Press Inc."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1021\/jf9801973","article-title":"Antioxidant activity and total phenolics in selected fruits, vegetables, and grain products","volume":"46","author":"Velioglu","year":"1998","journal-title":"J. Agric. Food chem."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1081\/FRI-200040606","article-title":"Extraction of polyphenolics from plant material for functional foods\u2014Engineering and technology","volume":"21","author":"Shi","year":"2005","journal-title":"Food Rev. Int."},{"key":"ref_259","first-page":"3823","article-title":"Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells","volume":"60","author":"Wenzel","year":"2000","journal-title":"Cancer Res."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4161\/oxim.2.5.9498","article-title":"Plant polyphenols as dietary antioxidants in human health and disease","volume":"2","author":"Pandey","year":"2009","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jff.2015.06.018","article-title":"Phenolics and polyphenolics in foods, beverages and spices: Antioxidant activity and health effects\u2014A review","volume":"18","author":"Shahidi","year":"2015","journal-title":"J. Funct. Foods"},{"key":"ref_262","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez, S., Gasc\u00f3n, S., Luqu\u00edn, A., Laguna, M., Ancin-Azpilicueta, C., and Rodr\u00edguez-Yoldi, M.J. (2016). Rosa canina extracts have antiproliferative and antioxidant effects on caco-2 human colon cancer. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0159136"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3181\/0712-MR-336","article-title":"Mercury in traditional medicines: Is cinnabar toxicologically similar to common mercurials?","volume":"233","author":"Liu","year":"2008","journal-title":"Exp. Boil. Med."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaad.2010.06.014","article-title":"Silver sulfadiazine for the treatment of partial-thickness burns and venous stasis ulcers","volume":"66","author":"Miller","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3892\/etm.2015.2846","article-title":"Effects of a combination of puerarin, baicalin and berberine on the expression of proliferator-activated receptor-\u03b3 and insulin receptor in a rat model of nonalcoholic fatty liver disease","volume":"11","author":"Zhao","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cbpa.2014.02.003","article-title":"Metal-based anticancer chemotherapeutic agents","volume":"19","author":"Muhammad","year":"2014","journal-title":"Curr. Opin. Chem. Boil."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/156802612799078964","article-title":"Next-generation anticancer metallodrugs","volume":"12","author":"Komeda","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2174\/156802611794785226","article-title":"Transition metal based anticancer drugs","volume":"11","author":"Grant","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2174\/138161210791209009","article-title":"Novel metals and metal complexes as platforms for cancer therapy","volume":"16","author":"Frezza","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"8113","DOI":"10.1039\/c0dt00292e","article-title":"The status of platinum anticancer drugs in the clinic and in clinical trials","volume":"39","author":"Wheate","year":"2010","journal-title":"Dalton Trans."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"583","DOI":"10.18388\/abp.2002_3768","article-title":"Recognition and repair of DNA-cisplatin adducts","volume":"49","author":"WoYniak","year":"2002","journal-title":"Acta Biochim. Pol."},{"key":"ref_273","doi-asserted-by":"crossref","unstructured":"Johnstone, T.C., Suntharalingam, K., and Lippard, S.J. (2015). Third row transition metals for the treatment of cancer. Philos. Trans. R. Soc. Lond. A Math. Phys. Eng. Sci.","DOI":"10.1098\/rsta.2014.0185"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2015.06.012","article-title":"An integrated view of cisplatin-induced nephrotoxicity and ototoxicity","volume":"237","author":"Karasawa","year":"2015","journal-title":"Toxicol. Lett."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5935\/0101-2800.20130052","article-title":"Acute nephrotoxicity of cisplatin: Molecular mechanisms","volume":"35","author":"Peres","year":"2013","journal-title":"J. Bras. Nefrol."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1017\/S0022215113000947","article-title":"Mechanisms of cisplatin ototoxicity: Theoretical review","volume":"127","author":"Silveira","year":"2013","journal-title":"J. Laryngol. Otol."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: Mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.phrs.2016.01.001","article-title":"Cisplatin resistance and opportunities for precision medicine","volume":"106","author":"Amable","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clcc.2011.10.004","article-title":"Literature review and practical aspects on the management of oxaliplatin-associated toxicity","volume":"11","author":"Hoff","year":"2012","journal-title":"Clin. Colorectal Cancer"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"18","author":"Figer","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev-med-051513-102539","article-title":"Recent therapeutic advances in the treatment of colorectal cancer","volume":"66","author":"Ciombor","year":"2015","journal-title":"Ann. Rev. Med."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2174\/0929867321666131217161849","article-title":"Metal-N-heterocyclic carbene complexes as anti-tumor agents","volume":"21","author":"Hu","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1142\/S1088424615500236","article-title":"Synthesis and anti-cancer activities of a water soluble gold (III) porphyrin","volume":"19","author":"Lammer","year":"2015","journal-title":"J. Porphyr. Phthalocyanines"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1039\/C2CC37366A","article-title":"A gold (III) porphyrin complex as an anti-cancer candidate to inhibit growth of cancer-stem cells","volume":"49","author":"Lum","year":"2013","journal-title":"Chem. Commun."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2741\/s274","article-title":"New applications of old metal-binding drugs in the treatment of human cancer","volume":"4","author":"Schmitt","year":"2012","journal-title":"Front. Biosci."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2165\/00003495-198427050-00002","article-title":"Auranofin","volume":"27","author":"Chaffman","year":"1984","journal-title":"Drugs"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40268-015-0083-y","article-title":"Auranofin: Repurposing an old drug for a golden new age","volume":"15","author":"Roder","year":"2015","journal-title":"Drugs R&D"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.freeradbiomed.2006.12.021","article-title":"Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells","volume":"42","author":"Marzano","year":"2007","journal-title":"Free Rad. Biol. Med."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jinorgbio.2013.09.019","article-title":"Strong inhibition of thioredoxin reductase by highly cytotoxic gold (I) complexes. DNA binding studies","volume":"130","author":"Ortego","year":"2014","journal-title":"J. Inorg. Biochem."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00775-016-1338-y","article-title":"Novel antitumor adamantane-azole gold (I) complexes as potential inhibitors of thioredoxin reductase","volume":"21","author":"Garcia","year":"2016","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1039\/c2dt11781a","article-title":"Synthesis and characterization of azolate gold (I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents","volume":"41","author":"Galassi","year":"2012","journal-title":"Dalton Trans."},{"key":"ref_293","doi-asserted-by":"crossref","unstructured":"Tsuji, P.A., Carlson, B.A., Yoo, M.-H., Naranjo-Suarez, S., Xu, X.-M., He, Y., Asaki, E., Seifried, H.E., Reinhold, W.C., and Davis, C.D. (2015). The 15 kDa selenoprotein and thioredoxin reductase 1 promote colon cancer by different pathways. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124487"},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1089\/ars.2012.4757","article-title":"The thioredoxin system as a therapeutic target in human health and disease","volume":"19","author":"Mahmood","year":"2013","journal-title":"Antioxid. Redox signal."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1517\/13543784.15.9.1067","article-title":"The potential of proteasome inhibition in the treatment of colon cancer","volume":"15","author":"Konstantinopoulos","year":"2006","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"457","DOI":"10.18632\/oncoscience.167","article-title":"Inhibition of 19s proteasome-associated deubiquitinases by metal-containing compounds","volume":"2","author":"Liu","year":"2015","journal-title":"Oncoscience"},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2174\/138955712802762040","article-title":"Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells","volume":"12","author":"Buac","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jcb.22394","article-title":"Inhibition of tumor proteasome activity by gold-dithiocarbamato complexes via both redox-dependent and-independent processes","volume":"109","author":"Zhang","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1021\/om400340a","article-title":"S-propargylthiopyridine phosphane derivatives as anticancer agents: Characterization and antitumor activity","volume":"32","author":"Cerrada","year":"2013","journal-title":"Organometallics"},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejmech.2014.04.001","article-title":"Gold (I) complexes with alkylated PTA (1,3,5-triaza-7-phosphaadamantane) phosphanes as anticancer metallodrugs","volume":"79","author":"Cerrada","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2174\/1871520615666150129211440","article-title":"In vivo anticancer activity, toxicology and histopathological studies of the thiolate gold (I) complex [Au(Spyrimidine)(PTA-CH2Ph)]Br","volume":"15","author":"Romanos","year":"2015","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1039\/C5DT01802A","article-title":"In vitro and in vivo evaluation of organometallic gold (I) derivatives as anticancer agents","volume":"45","author":"Romanos","year":"2016","journal-title":"Dalton Trans."},{"key":"ref_303","doi-asserted-by":"crossref","unstructured":"Atri\u00e1n-Blasco, E., Gasc\u00f3n, S., Rodr\u00edguez-Yoldi, M.J., Laguna, M., and Cerrada, E. (2016). Synthesis of gold (I) derivatives bearing alkylated 1,3,5-triaza-7-phosphaadamantane as selective anticancer metallodrugs. Eur. J. Inorg. Chem., 2791\u20132803.","DOI":"10.1002\/ejic.201600177"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/1\/197\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:26:33Z","timestamp":1760207193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/1\/197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,19]]},"references-count":303,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1]]}},"alternative-id":["ijms18010197"],"URL":"https:\/\/doi.org\/10.3390\/ijms18010197","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,19]]}}}